Cargando…

Blood pressure control to prevent decline in cognition after stroke

BACKGROUND: Treatment of hypertension post-stroke preserves cognition through prevention of recurrent stroke, but it is not clear whether it prevents cognitive decline through other mechanisms. We aimed to describe changes in blood pressure from baseline to 1 year post-stroke and to evaluate the ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Ihle-Hansen, Hege, Thommessen, Bente, Fagerland, Morten W, Øksengård, Anne R, Wyller, Torgeir B, Engedal, Knut, Fure, Brynjar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467749/
https://www.ncbi.nlm.nih.gov/pubmed/26089677
http://dx.doi.org/10.2147/VHRM.S82839
_version_ 1782376407348805632
author Ihle-Hansen, Hege
Thommessen, Bente
Fagerland, Morten W
Øksengård, Anne R
Wyller, Torgeir B
Engedal, Knut
Fure, Brynjar
author_facet Ihle-Hansen, Hege
Thommessen, Bente
Fagerland, Morten W
Øksengård, Anne R
Wyller, Torgeir B
Engedal, Knut
Fure, Brynjar
author_sort Ihle-Hansen, Hege
collection PubMed
description BACKGROUND: Treatment of hypertension post-stroke preserves cognition through prevention of recurrent stroke, but it is not clear whether it prevents cognitive decline through other mechanisms. We aimed to describe changes in blood pressure from baseline to 1 year post-stroke and to evaluate the association between achieved blood pressure targets and cognitive function, mild cognitive impairment (MCI), and dementia. METHODS: We included patients with first-ever stroke, and defined achieved blood pressure goals as systolic blood pressure (SBP) in the categories ≤125 mmHg, ≤140 mmHg, and ≤160 mmHg, SBP reduction of ≥10 mmHg, and diastolic blood pressure (DBP) reduction of ≥5 mmHg. The main outcome variables were cognitive assessments 1 year post stroke. Secondary outcomes were diagnoses of MCI or dementia. RESULTS: Forty-one of 166 patients (25%) reached SBP ≤125 mmHg after 1 year, 92/166 (55%) reached SBP ≤140 mmHg, and 150/166 (90%) reached SBP ≤160 mmHg. SBP was reduced by ≥10 mmHg in 44/150 (29%) and DBP by ≥5 mmHg in 57/150 (38%). We did not find any statistically significant associations between cognitive test performances and different blood pressure goals (P=0.070–1.0). Nor was there any significant association between achieved goal blood pressure or blood pressure reduction after 1 year and the diagnoses of MCI or dementia (P=0.32–0.56). CONCLUSION: Treatment of hypertension is important for primary and secondary prevention of stroke. Showing a potential beneficial effect of blood pressure control on cognitive function, however, probably needs longer follow-up.
format Online
Article
Text
id pubmed-4467749
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44677492015-06-18 Blood pressure control to prevent decline in cognition after stroke Ihle-Hansen, Hege Thommessen, Bente Fagerland, Morten W Øksengård, Anne R Wyller, Torgeir B Engedal, Knut Fure, Brynjar Vasc Health Risk Manag Original Research BACKGROUND: Treatment of hypertension post-stroke preserves cognition through prevention of recurrent stroke, but it is not clear whether it prevents cognitive decline through other mechanisms. We aimed to describe changes in blood pressure from baseline to 1 year post-stroke and to evaluate the association between achieved blood pressure targets and cognitive function, mild cognitive impairment (MCI), and dementia. METHODS: We included patients with first-ever stroke, and defined achieved blood pressure goals as systolic blood pressure (SBP) in the categories ≤125 mmHg, ≤140 mmHg, and ≤160 mmHg, SBP reduction of ≥10 mmHg, and diastolic blood pressure (DBP) reduction of ≥5 mmHg. The main outcome variables were cognitive assessments 1 year post stroke. Secondary outcomes were diagnoses of MCI or dementia. RESULTS: Forty-one of 166 patients (25%) reached SBP ≤125 mmHg after 1 year, 92/166 (55%) reached SBP ≤140 mmHg, and 150/166 (90%) reached SBP ≤160 mmHg. SBP was reduced by ≥10 mmHg in 44/150 (29%) and DBP by ≥5 mmHg in 57/150 (38%). We did not find any statistically significant associations between cognitive test performances and different blood pressure goals (P=0.070–1.0). Nor was there any significant association between achieved goal blood pressure or blood pressure reduction after 1 year and the diagnoses of MCI or dementia (P=0.32–0.56). CONCLUSION: Treatment of hypertension is important for primary and secondary prevention of stroke. Showing a potential beneficial effect of blood pressure control on cognitive function, however, probably needs longer follow-up. Dove Medical Press 2015-06-09 /pmc/articles/PMC4467749/ /pubmed/26089677 http://dx.doi.org/10.2147/VHRM.S82839 Text en © 2015 Ihle-Hansen et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Ihle-Hansen, Hege
Thommessen, Bente
Fagerland, Morten W
Øksengård, Anne R
Wyller, Torgeir B
Engedal, Knut
Fure, Brynjar
Blood pressure control to prevent decline in cognition after stroke
title Blood pressure control to prevent decline in cognition after stroke
title_full Blood pressure control to prevent decline in cognition after stroke
title_fullStr Blood pressure control to prevent decline in cognition after stroke
title_full_unstemmed Blood pressure control to prevent decline in cognition after stroke
title_short Blood pressure control to prevent decline in cognition after stroke
title_sort blood pressure control to prevent decline in cognition after stroke
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467749/
https://www.ncbi.nlm.nih.gov/pubmed/26089677
http://dx.doi.org/10.2147/VHRM.S82839
work_keys_str_mv AT ihlehansenhege bloodpressurecontroltopreventdeclineincognitionafterstroke
AT thommessenbente bloodpressurecontroltopreventdeclineincognitionafterstroke
AT fagerlandmortenw bloodpressurecontroltopreventdeclineincognitionafterstroke
AT øksengardanner bloodpressurecontroltopreventdeclineincognitionafterstroke
AT wyllertorgeirb bloodpressurecontroltopreventdeclineincognitionafterstroke
AT engedalknut bloodpressurecontroltopreventdeclineincognitionafterstroke
AT furebrynjar bloodpressurecontroltopreventdeclineincognitionafterstroke